Mapping pathogenesis of arthritis through small animal models

Rheumatology (United Kingdom)

Volumn 51, Issue 11, 2012, Pages 1931-1941

  Vincent, Tonia L ^a   Williams, Richard O ^a   Maciewicz, Rose ^b   Silman, Alan ^c   Garside, Paul ^d   Bevan, Stuart ^e   Chanalaris, Anastasios ^f   Chapman, Victoria ^g   Cope, Andrew ^e   Cruwys, Simon ^b   Dell'Accio, Francesco ^h   Gaskin, Pam ⁱ   Gilroy, Derek ^j   Glasson, Sonya ^k   Hegen, Martin ^l   McDougall, Jason ^m   Moore, Adrian ⁿ   du Sert, Nathalie Percie ^o   Perretti, Mauro ^h   Pitsillides, Andrew ^p   Robinson, Vicky ^o   Seed, Michael ^h   Thompson, Stephen ^e   Walsh, David A ^g   Williams, Neil ^q   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c Medical Director Arthritis Research UK   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ GLAXOSMITHKLINE   (United Kingdom)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k Previously of Wyeth   (United Kingdom)

^l PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^m UNIVERSITY OF CALGARY   (Canada)

ⁿ UCB PHARMA   (Belgium)

^o National Centre for the Replacement   (United Kingdom)

^p ROYAL VETERINARY COLLEGE   (United Kingdom)

^q UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

Animal model; Arthritis; Genetic modification; Inflammation; Knockout; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; DISEASE MODEL; HUMAN; IN VIVO STUDY; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

EID: 84867812304     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes035     Document Type: Review

References (89)

1. Kollias G, Papadaki P, Apparailly F et al. Animal models for arthritis: innovative tools for prevention and treatment. Ann Rheum Dis 2011; 70: 1357-62.
2. Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002; 4(Suppl. 3): S265-72.
3. Janossy G, Panayi G, Duke O et al. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet 1981; 2: 839-42.
4. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 1982; 79: 3632-6.
5. Verburg RJ, Flierman R, Sont JK et al. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration. Ann Rheum Dis 2005; 64: 1397-405.
6. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-6.
7. Raychaudhuri S, Thomson BP, Remmers EF et al. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet 2009; 41: 1313-8.
8. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna L. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001; 44: 2777-89.
9. Sato T, Konomi K, Yamasaki S et al. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum 2006; 54: 808-17.
10. Aigner T, Fundel K, Saas J et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006; 54: 3533-44.
11. Glasson SS, Askew R, Sheppard B et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005; 434: 644-8.
12. Little CB, Barai A, Burkhardt D et al. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 2009; 60: 3723-33.
13. Sun Y, Mauerhan DR, Honeycutt PR et al. Analysis of meniscal degeneration and meniscal gene expression. BMC Musculoskelet Disord 2010; 11: 19.
14. Goldring MB, Goldring SR. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann NY Acad Sci 2010; 1192: 230-7.
15. Bassiouni HM. Bone marrow lesions in the knee: the clinical conundrum. Int J Rheum Dis 2010; 13: 196-202.
16. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010; 6: 625-35.
17. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology 2005; 44: 7-16.
18. Benson RA, Patakas A, McQueenie R et al. Arthritis in space and time-to boldly go! FEBS Lett 2011; 1: 3640-8.
19. van den Berg WB. Lessons from animal models of arthritis over the past decade. Arthritis Res Ther 2009; 11: 250.
20. Patel HG. Fundamentals of Inflammation. Cambridge: Cambridge University Press, 2010.
21. Keffer J, Probert L, Cazlaris H et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991; 10: 4025-31.
22. Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387-98.
23. Kouskoff V, Korganow AS, Duchatelle V. Organ-specific disease provoked by systemic autoimmunity. Cell 1996; 87: 811-22.
24. Peccoud J, Dellabona P, Allen P, Benoist C, Mathis D. Delineation of antigen contact residues on an MHC class II molecule. EMBO J 1990; 9: 4215-23.
25. Korganow AS, Ji H, Mangialaio S et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999; 10: 451-61.
26. Solomon S, Kolb C, Mohanty S et al. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). Eur J Immunol 2002; 32: 644-51.
27. Corr M, Crain B. The role of FcgammaR signaling in the K/ B x N serum transfer model of arthritis. J Immunol 2002; 169: 6604-9.
28. Ji H, Gauguier D, Ohmura K et al. Genetic influences on the end-stage effector phase of arthritis. J Exp Med 2001; 194: 321-30.
29. Sakaguchi N, Takahashi T, Hata H et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-60.
30. Yoshitomi H, Sakaguchi N, Kobayashi K et al. A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 2005; 201: 949-60.
31. Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med 1956; 91: 95-101.
32. Holmdahl R, Lorentzen JC, Lu S et al. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev 2001; 184: 184-202.
33. Chang YH, Pearson CM, Abe C. Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies. Arthritis Rheum 1980; 23: 62-71.
34. Holmdahl R, Goldschmidt TJ, Kleinau S, Kvick C, Jonsson R. Arthritis induced in rats with adjuvant oil is a genetically restricted, alpha beta T-cell dependent autoimmune disease. Immunology 1992; 76: 197-202.
35. Holmdahl R, Andersson ME, Goldschmidt TJ et al. Collagen induced arthritis as an experimental model for rheumatoid arthritis. Immunogenetics, pathogenesis and autoimmunity. APMIS 1989; 97: 575-84.
36. Trentham DE. Collagen arthritis as a relevant model for rheumatoid arthritis: evidence pro and con. Arthritis Rheum 1982; 25: 911-6.
37. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 1992; 89: 9784-8.
38. Glant TT, Mikecz K, Arzoumanian A, Poole AR. Proteoglycan-induced arthritis in BALB/c mice. Clinical features and histopathology. Arthritis Rheum 1987; 30: 201-12.
39. Bardos T, Szabo Z, Czipri M et al. A longitudinal study on an autoimmune murine model of ankylosing spondylitis. Ann Rheum Dis 2005; 64: 981-7.
40. Davis LS, Sackler M, Brezinschek RI et al. Inflammation, immune reactivity, and angiogenesis in a severe combined immunodeficiency model of rheumatoid arthritis. Am J Pathol 2002; 160: 357-67.
41. Wahid S, Blades MC, De Lord D et al. Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice. Clin Exp Immunol 2000; 122: 133-42.
42. Inglis JJ, McNamee KE, Chia SL et al. Regulation of pain sensitivity in experimental osteoarthritis by the endogenous peripheral opioid system. Arthritis Rheum 2008; 58: 3110-9.
43. McNamee KE, Burleigh A, Gompels LL et al. Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain 2010; 149: 386-92.
44. Daans M, Luyten FP, Lories RJ. GDF5 deficiency in mice is associated with instability-driven joint damage, gait and subchondral bone changes. Ann Rheum Dis 2011; 70: 208-13.
45. Brandt KD, Dieppe P, Radin EL. Commentary: is it useful to subset 'primary' osteoarthritis? A critique based on evidence regarding the etiopathogenesis of osteoarthritis. Semin Arthritis Rheum 2009; 39: 81-95.
46. Ma HL, Blanchet TJ, Peluso D et al. Osteoarthritis severity is sex dependent in a surgical mouse model. Osteoarthritis Cartilage 2007; 15: 695-700.
47. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
48. Kuro-o M. Klotho and aging. Biochim Biophys Acta 2009; 1790: 1049-58.
49. Haigis MC, Yankner BA. The aging stress response. Mol Cell 2010; 40: 333-44.
50. McDougall JJ, Andruski B, Schuelert N, Hallgrimsson B, Matyas JR. Unravelling the relationship between age, nociception and joint destruction in naturally occurring osteoarthritis of Dunkin Hartley guinea pigs. Pain 2009; 141: 222-32.
51. Inglis JJ, Simelyte E, McCann FE, Criado G, Williams RO. Protocol for the induction of arthritis in C57BL/6 mice. Nat Protoc 2008; 3: 612-8.
52. Chen M, Lichtler AC, Sheu TJ et al. Generation of a transgenic mouse model with chondrocyte-specific and tamoxifen-inducible expression of Cre recombinase. Genesis 2007; 45: 44-50.
53. Nakamura E, Nguyen MT, Mackem S. Kinetics of tamoxifen-regulated Cre activity in mice using a cartilage-specific CreER(T) to assay temporal activity windows along the proximodistal limb skeleton. Dev Dyn 2006; 235: 2603-12.
54. Henry SP, Jang CW, Deng JM. Generation of aggrecan-CreERT2 knockin mice for inducible Cre activity in adult cartilage. Genesis 2009; 47: 805-14.
55. Grover J, Roughley PJ. Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration. Matrix Biol 2006; 25: 158-65.
56. Rountree RB, Schoor M, Chen H et al. BMP receptor signaling is required for postnatal maintenance of articular cartilage. PLoS Biol 2004; 2: e355.
57. Ferrell WR, Kelso EB, Lockhart JC, Plevin R, McInnes IB. Protease-activated receptor 2: a novel pathogenic pathway in a murine model of osteoarthritis. Ann Rheum Dis 2010; 69: 2051-4.
58. Shen PC, Wu CL, Jou IM et al. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1gamma. Osteoarthritis Cartilage 2011; 19: 728-36.
59. Clements KM, Flannelly JK, Tart J et al. Matrix metalloproteinase is necessary for cartilage aggrecan degradation in an inflammatory environment. Ann Rheum Dis 2011; 70: 683-9.
60. Okamura N, Hasegawa M, Nakoshi Y et al. Deficiency of tenascin-C delays articular cartilage repair in mice. Osteoarthr Cartil 2010; 18: 839-48.
61. Xu L, Servais J, Polur I et al. Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum 2010; 62: 2736-44.
62. Otsuki S, Hanson SR, Miyaki S et al. Extracellular sulfatases support cartilage homeostasis by regulating BMP and FGF signaling pathways. Proc Natl Acad Sci USA 2010; 107: 10202-7.
63. Echtermeyer F, Bertrand J, Dreier R et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 2009; 15: 1072-6.
64. Yang S, Kim J, Ryu JH et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010; 16: 687-93.
65. Saito T, Fukai A, Mabuchi A et al. Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 2010; 16: 678-86.
66. Chia SL, Sawaji Y, Burleigh A et al. Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 2009; 60: 2019-27.
67. Matsui Y, Iwasaki N, Kon S et al. Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice. Arthritis Rheum 2009; 60: 2362-71.
68. Yamakawa K, Kamekura S, Kawamura N et al. Association of microsomal prostaglandin E synthase 1 deficiency with impaired fracture healing, but not with bone loss or osteoarthritis, in mouse models of skeletal disorders. Arthritis Rheum 2008; 58: 172-83.
69. Shimizu S, Asou Y, Itoh S et al. Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis. Arthritis Rheum 2007; 56: 3358-65.
70. Majumdar MK, Askew R, Schelling S et al. Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis. Arthritis Rheum 2007; 56: 3670-4.
71. Kamekura S, Kawasaki Y, Hoshi K et al. Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum 2006; 54: 2462-70.
72. Glasson SS, Askew R, Sheppard B et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum 2004; 50: 2547-58.
73. Clements KM, Price JS, Chambers MG et al. Gene deletion of either interleukin-1beta, interleukin-1betaconverting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy. Arthritis Rheum 2003; 48: 3452-63.
74. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
75. Glasson SS, Chambers MG, Van Den Berg WB, Little CB. The OARSI histopathology initiative-recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage 2010; 18(Suppl. 3): S17-23.
76. Aigner T, Cook JL, Gerwin N et al. Histopathology atlas of animal model systems-overview of guiding principles. Osteoarthritis Cartilage 2010; 18(Suppl. 3): S2-6.
77. Farkas B, Boldizsar F, Tarjanyi O et al. BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance. Arthritis Res Ther 2009; 11: R21.
78. Thomason M, Bywater EGC. Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962; 21: 370-7.
79. Glick EN. Asymmetrical rheumatoid arthritis after poliomyelitis. Br Med J 1967; 3: 26-8.
80. Stecher RM, Karnosh LJ. Heberden's nodes; the effect of nerve injury upon the formation of degenerative joint disease of the fingers. Am J Med Sci 1947; 213: 181-91.
81. Etherington J, Spector TD. Asymmetrical nodular osteoarthritis in a patient with a hemiparesis. Ann Rheum Dis 1995; 54: 936-7.
82. Stanton H, Rogerson FM, East CJ et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005; 434: 648-52.
83. Simmen BR, Huber H. The wrist joint in chronic polyarthritis- a new classification based on the type of destruction in relation to the natural course and the consequences for surgical therapy. Handchir Mikrochir Plast Chir 1994; 26: 182-9.
84. Wegner N, Lundberg K, Kinloch A et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010; 233: 34-54.
85. Dell'accio F, Vincent TL. Joint surface defects: clinical course and cellular response in spontaneous and experimental lesions. Eur Cell Mater 2010; 20: 210-7.
86. Marijnissen AC, Van Roermund PM, Van Melkebeek J et al. Clinical benefit of joint distraction in the treatment of severe osteoarthritis of the ankle: proof of concept in an open prospective study and in a randomized controlled study. Arthritis Rheum 2002; 46: 2893-902.
87. Eltawil NM, De Bari C, Achan P, Pitzalis C, Dell'accio F. A novel in vivo murine model of cartilage regeneration. Age and strain-dependent outcome after joint surface injury. Osteoarthritis Cartilage 2009; 17: 695-704.
88. Noel D, Gazit D, Bouquet C et al. Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells 2004; 22: 74-85.
89. Lories RJU. Animal models of spondyloarthritis. Curr Opin Rheumatol 2006; 18: 342-6.